181 related articles for article (PubMed ID: 36635262)
41. Second cancers in patients with chronic lymphocytic leukemia.
Travis LB; Curtis RE; Hankey BF; Fraumeni JF
J Natl Cancer Inst; 1992 Sep; 84(18):1422-7. PubMed ID: 1512794
[TBL] [Abstract][Full Text] [Related]
42. Second primary malignancies in chronic myeloid leukemia.
Shah BK; Ghimire KB
Indian J Hematol Blood Transfus; 2014 Dec; 30(4):236-40. PubMed ID: 25435720
[TBL] [Abstract][Full Text] [Related]
43. Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study.
Chen SC; Teng CJ; Hu YW; Yeh CM; Hung MH; Hu LY; Ku FC; Tzeng CH; Chiou TJ; Chen TJ; Liu CJ
PLoS One; 2015; 10(1):e0116384. PubMed ID: 25635388
[TBL] [Abstract][Full Text] [Related]
44. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.
Levi F; Randimbison L; Te VC; La Vecchia C
Br J Cancer; 1996 Dec; 74(11):1847-50. PubMed ID: 8956805
[TBL] [Abstract][Full Text] [Related]
45. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract][Full Text] [Related]
46. Characterization of Second Primary Malignancies in Mucosa-Associated Lymphoid Tissue Lymphomas: A SEER Database Interrogation.
Timilsina S; Damato A; Budhathoki N; Grossbard ML; Braunstein M
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):76-81. PubMed ID: 34493476
[TBL] [Abstract][Full Text] [Related]
47. Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different Treatments.
Su VY; Liu CJ; Chen YM; Chou TY; Chen TJ; Yen SH; Chiou TJ; Liu JH; Hu YW
Target Oncol; 2017 Apr; 12(2):219-227. PubMed ID: 27766477
[TBL] [Abstract][Full Text] [Related]
48. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
49. Risk of hematological malignancy in blood donors: A nationwide cohort study.
Zhao J; Dahlén T; Brynolf A; Edgren G
Transfusion; 2020 Nov; 60(11):2591-2596. PubMed ID: 32818321
[TBL] [Abstract][Full Text] [Related]
50. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
51. Second primary malignancies after ocular adnexal lymphoma diagnosis.
Loya A; Ramachandran V; Ayaz T; Weng CY
BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
[TBL] [Abstract][Full Text] [Related]
52. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
[TBL] [Abstract][Full Text] [Related]
53. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
54. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
55. Solid tumors after chronic lymphocytic leukemia.
Hisada M; Biggar RJ; Greene MH; Fraumeni JF; Travis LB
Blood; 2001 Sep; 98(6):1979-81. PubMed ID: 11535538
[TBL] [Abstract][Full Text] [Related]
56. Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study.
Beiggi S; Johnston JB; Seftel MD; Pitz MW; Kumar R; Banerji V; Griffith EJ; Gibson SB
Br J Cancer; 2013 Sep; 109(5):1287-90. PubMed ID: 23860531
[TBL] [Abstract][Full Text] [Related]
57. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Tsimberidou AM; Wen S; McLaughlin P; O'Brien S; Wierda WG; Lerner S; Strom S; Freireich EJ; Medeiros LJ; Kantarjian HM; Keating MJ
J Clin Oncol; 2009 Feb; 27(6):904-10. PubMed ID: 19114699
[TBL] [Abstract][Full Text] [Related]
58. The association between histological subtype of a first primary endometrial cancer and second cancer risk.
Rhoades J; Vetter MH; Fisher JL; Cohn DE; Salani R; Felix AS
Int J Gynecol Cancer; 2019 Feb; 29(2):290-298. PubMed ID: 30718311
[TBL] [Abstract][Full Text] [Related]
59. Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study.
Ganti A; Plitt MA; Kuan EC; Kuhar HN; Batra PS; Tajudeen BA
Int Forum Allergy Rhinol; 2018 Jun; 8(6):756-762. PubMed ID: 29381260
[TBL] [Abstract][Full Text] [Related]
60. Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study.
Zhou B; Zang R; Song P; Zhang M; Bie F; Bai G; Li Y; Huai Q; Han Y; Gao S
J Transl Med; 2023 Jan; 21(1):10. PubMed ID: 36624443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
